GlassScriptPhysician profile
Mary Eileen Nashert
NPI 1710134713
$1,343.45
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.54 · 2022: $348 · 2023: $668 · 2024: $104 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $427.46 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $342.33 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $146.00 | 2022-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $131.99 | 2022-2023 | |
| Medtronic, INC. | $113.02 | 2025 | Micra |
| Boston Scientific Corporation | $96.25 | 2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $28.87 | 2022 | |
| Abbott Laboratories | $23.39 | 2023 | Cardiomems |
| Amgen INC. | $19.32 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Nashert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.